ArticleJournal of experimental & clinical cancer research : CR2021

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.

Mengkai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.